Primary Brain Tumors

Drugs are part of the treatment for auditory neuroma, and some progress has been made in research into systemic drug therapy for auditory neuroma, including antiretroviral (ART) drugs, anti-vascular endothelial growth factor (VEGF) drugs, and, receptor tyrosine kinase (RTK) inhibitors. We contribute to every brain tumor-related research project, including drug development for an auditory neuroma.

There is a growing interest in developing drug therapies for the control of pituitary tumor growth and/or hormone overproduction, and we will help you to better understand the molecular features of pituitary tumor secretion and proliferation mechanisms to provide the best support for research into multiple types of brain tumor disease.

With advances in genomics and the identification of driver mutations, we have helped researchers in this field to progressively advance their research into targeted drugs. Considering the research on new drugs, identifying and understanding new signaling pathways and factors will hopefully provide ideas for drug development.

In the tumor microenvironment, the variant immune checkpoint signaling pathway is an important immune escape mechanism. We are actively helping researchers to carry out more in-depth functional studies of multiple targets. In addition, we are also helping customers to actively explore further possibilities regarding combination therapies and vaccines in glioma research.

We can help customers to analyze the molecular profile of the enzymatic epidermal craniopharyngioma pathway to reveal potentially therapeutically relevant signaling pathways and thus advance the targeting of small molecule inhibitors. We can also help you identify the upregulation of several markers that may represent potential therapeutic targets.

We focus on choroid plexus tumorigenesis and progression, and we seek to provide you with deeper insights and accelerate your research in this area through a variety of solutions, including choroid plexus carcinoma mouse model, gene decoding, and genetic evaluation and, sequencing.